| A Study Evaluating the Efficacy and Safety of Afimetoran Compared With Placebo in Participants With Active Systemic Lupus Erythematosus (SLE) (NCT04895696) | Beeline Medicines Corporation | 2021-10-11 |
| A Study to Assess the Efficacy and Safety of HMI-115 in Subjects With Endometriosis-Associated Pain (NCT05101317) | Hope Medicine (Nanjing) Co., Ltd | 2021-10-11 |
| Efficacy and Safety of Intravitreal Injection of Bevacizumab with and Without Oral Curcumin (NCT06595355) | Isfahan University of Medical Sciences | 2021-10-10 |
| StrataGraft Overlay of Meshed Autograft in Full-thickness Thermal Burns (NCT04765202) | Stratatech, a Mallinckrodt Company | 2021-10-10 |
| Effect of Pre-emptive Intravenous Immunoglobulin (IVIG) on the Incidence of Septic Episodes in Pediatric Burn Patients (NCT05134792) | Cairo University | 2021-10-10 |
| Phase 2 Study of CAN008 in Subjects With GBM (NCT05447195) | CANbridge Life Sciences Ltd. | 2021-10-10 |
| Tislelizumab as Cross-line Treatment for Advanced NSCLC (NCT05192681) | Fujian Cancer Hospital | 2021-10-10 |
| Chemotherapy and Surgical Resection in Patients With Hepatic Oligometastatic Adenocarcinoma of the Pancreas (NCT04617457) | University of Cologne | 2021-10-10 |
| Study to Evaluate Tolerability of Iberdomide (CC-220) in Combination With Polatuzumab Vedotin Plus Rituximab or Tafasitamab or Rituximab Plus Chemotherapy in B-cell Lymphoma (NCT04882163) | Celgene | 2021-10-10 |
| Safety, Tolerability and Efficacy of Vaginal Suppositories for Treatment of the Endometriosis (NCT03481842) | BioGene Pharmaceutical Ltd. | 2021-10-10 |
| Granisetron Transdermal Patch System for Prevention of CINV by CapeOX (NCT05325190) | Tianjin Medical University Cancer Institute and Hospital | 2021-10-10 |
| Clinical Study of Camrelizumab Combined With SOX in the Adjuvant Treatment of Advanced Gastric Adenocarcinoma or Gastric Esophageal Junction Adenocarcinoma (NCT05184946) | The Second Affiliated Hospital of Shandong First Medical University | 2021-10-09 |
| To Explore the Efficacy and Safety of Camrelizumab Combined With SHR1020 in the Treatment of Advanced Melanoma (NCT05051865) | Peking University Cancer Hospital & Institute | 2021-10-09 |
| A Study to Evaluate the Antiviral Activity and Safety of HH-003 Injection in Subjects With HBeAg-Negative Chronic Hepatitis B Treated With Nucleos(t)Ide Reverse Transcriptase Inhibitors (NCT05839639) | Huahui Health | 2021-10-09 |
| A Study to Access Efficacy and Safety of P1101 in Chinese PV Patients Who Are Intolerant or Resistance to HU (NCT05485948) | PharmaEssentia | 2021-10-08 |
| Study to Assess the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of TB006 in Participants With Alzheimer's Disease (NCT05074498) | TrueBinding, Inc. | 2021-10-08 |
| Testing the Addition of Duvelisib or CC-486 to the Usual Treatment for Peripheral T-Cell Lymphoma (NCT04803201) | Alliance for Clinical Trials in Oncology | 2021-10-08 |
| Meropenem-FL058 Phase 2 Study in the Treatment of Complicated Urinary Tract Infections (NCT05060419) | Qilu Pharmaceutical Co., Ltd. | 2021-10-08 |
| Benefit of Amlodipine in HRT Cycle for Frozen Embryo Transfer in the Correction of Uterine Pulsatility Index (NCT04954196) | University Hospital, Montpellier | 2021-10-08 |
| A Study of SAR444245 Combined With Other Anticancer Therapies for the Treatment of Participants With HNSCC (Master Protocol) (Pegathor Head and Neck 204) (NCT05061420) | Sanofi | 2021-10-08 |
| Interdisciplinary Interventions to Address Pain Management Among Head and Neck Cancer Patients (NCT05077072) | M.D. Anderson Cancer Center | 2021-10-08 |
| A Clinical Study to Compare the Efficacy and Safety of AK105 Plus Anlotinib and Capecitabine/Oxaliplatin (CapeOx) , Anlotinib Plus CapeOx, Bevacizumab Plus CapeOx (NCT05068206) | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 2021-10-08 |
| Digoxin In Treatment of Alcohol Associated Hepatitis (NCT05014087) | Yale University | 2021-10-08 |
| Treating Heart Failure With hPSC-CMs (NCT03763136) | HELP Therapeutics Co., Ltd. | 2021-10-08 |
| Preventing High Blood Sugar in People Being Treated for Metastatic Breast Cancer (NCT05090358) | Memorial Sloan Kettering Cancer Center | 2021-10-08 |
| Clinical Study on Prevention and Treatment of Pyrotinib Associated Diarrhea With Traditional Chinese Medicine (NCT04988165) | Tianjin Medical University Cancer Institute and Hospital | 2021-10-08 |
| Study of Safety and Efficacy of Pembrolizumab and Chemotherapy in Participants With Newly Diagnosed Classical Hodgkin Lymphoma (cHL) (MK-3475-C11/KEYNOTE-C11) (NCT05008224) | Merck Sharp & Dohme LLC | 2021-10-07 |
| A Study to Learn About the Study Medicine (Elranatamab) in Participants With Multiple Myeloma That Has Come Back After Responding to Treatment or Has Not Responded to Treatment (NCT05014412) | Pfizer | 2021-10-07 |
| A Study Evaluating the Efficacy and Safety of Biomarker-Driven Therapies in Patients With Persistent or Recurrent Rare Epithelial Ovarian Tumors (NCT04931342) | Hoffmann-La Roche | 2021-10-07 |
| Safety and Efficacy of AMT-130 in European Adults With Early Manifest Huntington's Disease (NCT05243017) | UniQure Biopharma B.V. | 2021-10-07 |
| CapTemY90 for Grade 2/3 NET Liver Metastases (NCT04339036) | Abramson Cancer Center at Penn Medicine | 2021-10-07 |
| Nitrous Oxide for PTSD (NCT04378426) | VA Office of Research and Development | 2021-10-07 |
| Total Body Irradiation and Cladribine Before Allogeneic Hematopoietic Cell Transplantation in Patients With AML (Acute Myeloid Leukemia) and Myelodysplastic Syndromes (NCT04861207) | Maria Sklodowska-Curie National Research Institute of Oncology | 2021-10-07 |
| Scalp Cooling in MBC (NCT04986579) | Dana-Farber Cancer Institute | 2021-10-07 |
| ERG/5-HTP in Fragile X Syndrome (FXS) (NCT05030129) | Elizabeth Berry-Kravis | 2021-10-07 |
| ITIL-168 in Advanced Melanoma (NCT05050006) | Instil Bio | 2021-10-07 |
| Study on an Investigational Yellow Fever Vaccine Compared With Stamaril in Adults in Europe and Asia (NCT05011123) | Sanofi Pasteur, a Sanofi Company | 2021-10-07 |
| A Phase I/II Open Label Single Centre Trial to Assess the Safety, Tolerability and Efficacy of Single Dose Neoadjuvant Anti-CLEVER-1 Antibody Bexmarilimab in Localised Renal Cell and Colon Carcinoma (NCT05104905) | Faron Pharmaceuticals Ltd | 2021-10-07 |
| JAK 1/2 Inhibitor, Baricitinib, in the Treatment of Adult IIM (NCT04208464) | University of Manchester | 2021-10-07 |
| Exercise Plus Duloxetine for Knee Osteoarthritis (NCT04111627) | University of Maryland, Baltimore | 2021-10-07 |
| Safely Stopping Pre-medications in Patients With Breast Cancer Who Are Receiving Paclitaxel (NCT04862585) | Ohio State University Comprehensive Cancer Center | 2021-10-07 |
| Venetoclax Combining With Fludarabine and Melphalan as Conditioning Regimen for Allo-HSCT (NCT05084027) | First Affiliated Hospital of Zhejiang University | 2021-10-07 |
| Semaglutide for the Treatment of Cognitive Dysfunction in Major Depressive Disorder (NCT04466345) | University Health Network, Toronto | 2021-10-06 |
| Mesenchymal Stromal Cells as Treatment for Digital Ulcers in Systemic Sclerosis (NCT03211793) | UMC Utrecht | 2021-10-06 |
| Study the Safety and Efficacy of DBI-001 Gel Versus Aqueous Gel (NCT05253755) | DermBiont, Inc. | 2021-10-06 |
| Microscopic Fluorescence-guided Vestibular Schwannoma Resection Using Fluorescein Sodium and YELLOW 560 (NCT04351373) | Mayo Clinic | 2021-10-06 |
| A Study of SEA-CD40 Given With Other Drugs in Cancers (NCT04993677) | Seagen Inc. | 2021-10-06 |
| Study of LM-102 in Patients With Advance Solid Tumors (NCT05008445) | LaNova Medicines Development Co., Ltd. | 2021-10-06 |
| Exploratory Study of Dipraglurant (ADX48621) for the Treatment of Patients With Blepharospasm (NCT05027997) | Addex Pharma S.A. | 2021-10-06 |
| Window of Opportunity Study of Preoperative Immunotherapy With Atezolizumab in Local SCCHN (NCT04939480) | University Hospital, Essen | 2021-10-06 |
| Ad26.ZEBOV Booster in HIV+ Adults Previously Vaccinated With Ad26.ZEBOV/MVA-BN-Filo (EBOVAC HIV+ Booster Study) (NCT05064956) | London School of Hygiene and Tropical Medicine | 2021-10-06 |
| A Study to the Assess the Change in Condition and Adverse Events of OnabotulinumtoxinA X Injection in Adult Participants With Glabellar Lines (NCT05100199) | Allergan | 2021-10-06 |
| Duvelisib in Combination With Nivolumab in Patients With Advanced Unresectable Melanoma (NCT04688658) | John Kirkwood | 2021-10-06 |
| Combined Intravitreal Bevacizumab With Topical Timolol-Dorzolamide Eye Drops in Diabetic Macular Edema (NCT05083689) | Shahid Beheshti University of Medical Sciences | 2021-10-06 |
| Virtual Reality-Assisted Cognitive Behavioral Therapy for Alcohol Dependence (CRAVR) (NCT05042180) | Psychiatric Centre Rigshospitalet | 2021-10-06 |
| Brain Insulin Resistance in Mood Disorders (NCT03915613) | University Health Network, Toronto | 2021-10-06 |
| A Study on the Safety and Immune Responses to the GVGH altSonflex1-2-3 Vaccine Against Shigellosis in Adults, Children, and Infants (NCT05073003) | GlaxoSmithKline | 2021-10-06 |
| Felzartamab in Late Antibody-Mediated Rejection (NCT05021484) | Farsad Eskandary | 2021-10-06 |
| Clinical Trial to Evaluate the Efficacy and Safety of DW4902 (NCT07319520) | Daewon Pharmaceutical Co., Ltd. | 2021-10-06 |
| To Evaluate if Green Tea Can be Effective in Reducing the Progression of Prostate Cancer in Men on Close Monitoring (NCT04597359) | ECOG-ACRIN Cancer Research Group | 2021-10-05 |
| A Study to Evaluate the Efficacy and Safety of Astegolimab in Participants With Chronic Obstructive Pulmonary Disease (NCT05037929) | Genentech, Inc. | 2021-10-05 |
| Pembrolizumab, Lenvatinib and Chemotherapy After TKIs in NSCLC (NCT04989322) | Dr Joanne CHIU | 2021-10-05 |
| Study Evaluating the Safety and Efficacy of Islatravir in Combination With Lenacapavir in Virologically Suppressed People With HIV (NCT05052996) | Gilead Sciences | 2021-10-05 |
| Brain Imaging Biomarkers in Patients With Brain Metastasis (NCT04197297) | University Health Network, Toronto | 2021-10-05 |
| Onapristone and Fulvestrant for ER+ HER2- Metastatic Breast Cancer After Endocrine Therapy and CDK4/6 Inhibitors (The SMILE Study) (NCT04738292) | University of Wisconsin, Madison | 2021-10-05 |
| Randomized, Double-Blind, Active Placebo-Controlled Study of Ketamine to Treat Levodopa-Induced Dyskinesia (NCT04912115) | PharmaTher Inc. | 2021-10-05 |
| BrUOG 397: NEO Rad (LOW): Neoadjuvant Low Dose Stereotactic Body Radiotherapy, Ipilimumab and Nivolumab (NCT04933903) | Brown University | 2021-10-05 |
| Safety, Efficacy and Pharmacokinetics of Rifaximin in Patients With Moderate-to-severe Papulopustular Rosacea (NCT05150587) | Alfasigma S.p.A. | 2021-10-05 |
| Obinutuzumab Versus Rituximab for Acute Lymphoblastic Leukemia/PALG ALL7 "OVERALL" (NCT04920968) | Maria Sklodowska-Curie National Research Institute of Oncology | 2021-10-05 |
| Safety and Efficacy of RPH-104 Used to Prevent Recurrent Fever Attacks in Adult Patients With Colchicine Resistant or Colchicine Intolerant Familial Mediterranean Fever (NCT05190991) | R-Pharm International, LLC | 2021-10-05 |
| A Phase I/II Study of Combination Immunotherapy for Advanced Cancers Including HPV-Associated Malignancies, Small Bowel, and Colon Cancers (NCT04708470) | National Cancer Institute (NCI) | 2021-10-05 |
| Study of Lacutamab in Peripheral T-cell Lymphoma (NCT04984837) | The Lymphoma Academic Research Organisation | 2021-10-05 |
| A Study to Evaluate TAlazoparib, Radiotherapy and Atezolizumab in gBRCA 1/2 Negative Patients With PD-L1+ Metastatic Triple Negative Breast Cancer (NCT04690855) | Mylin A. Torres, MD | 2021-10-04 |
| Sintilimab in Combination With Chidamide in Newly Diagnosed ENKTCL (NCT04994210) | Sun Yat-sen University | 2021-10-04 |
| A Phase 2 Open-Label Treatment Development Study of MDMA-Assisted Cognitive Processing Therapy (CPT) for Posttraumatic Stress Disorder (PTSD) (NCT05067244) | Remedy | 2021-10-04 |
| Noise-Induced Hearing Loss-Acute Exposure Treatment (NCT04768569) | Washington University School of Medicine | 2021-10-04 |
| A Study to Evaluate the Safety and Efficacy of RQC for AMD (NCT05062486) | Paul A Knepper, MD PhD | 2021-10-04 |
| Clinical Trial to Demonstrate the Effectiveness of Fecal Microbiota Transplantation for Selective Intestinal Decolonization of Patients Colonized by Carbapenemase-producing Klebsiella Pneumoniae (NCT04760665) | Maimónides Biomedical Research Institute of Córdoba | 2021-10-04 |
| "Prevention of Paclitaxel-Induced Peripheral Neuropathy in Breast Cancer Patients" (NCT05189535) | Ain Shams University | 2021-10-03 |
| Assessment of Growth Factors Levels Associated with Wound Healing After Soft Tissue Crown Lengthening (NCT06806319) | Al-Azhar University | 2021-10-03 |
| Safety Immunogenicity Study of MT-2766 in Japanese Adults（COVID-19） (NCT05065619) | Medicago | 2021-10-02 |
| Comparison Between RCT in Single and Two Visits, With and Without Intracanal Dressing, in Apical Repair (NCT05256667) | New York University | 2021-10-02 |
| Orismilast for the Treatment of Mild to Severe Hidradenitis Suppurativa (NCT04982432) | Gregor Jemec | 2021-10-01 |
| A Trial Measuring ART-123 Ability to Prevent Sensory Neuropathy in Unresectable mCRC Subjects w/Oxaliplatin-based Chemo (NCT04492436) | Veloxis Pharmaceuticals | 2021-10-01 |
| Study of AT-777 in Healthy Subjects and AT-777 in Combination With AT-527 in HCV-Infected Subjects (NCT04309734) | Atea Pharmaceuticals, Inc. | 2021-10-01 |
| Study on Immunogenicity, Reactogenicity and Safety of the VACΔ6 Vaccine in Volunteers Aged 18-60 Years (NCT05846243) | Federal Budgetary Research Institution State Research Center of Virology and Biotechnology "Vector" | 2021-10-01 |
| EON: A Single-arm Phase II Study of Etigilimab (OMP-313M32) in Combination With Checkpoint Inhibition (Nivolumab) in Patients With Platinum-resistant, Recurrent Epithelial Ovarian Cancer (NCT05715216) | M.D. Anderson Cancer Center | 2021-10-01 |
| Brentuximab Vedotin in Combination With CHEP in Patient With PTCL (NCT05006664) | Czech Lymphoma Study Group | 2021-10-01 |
| A Phase 1b-2 Trial to Assess Venetoclax and Navitoclax Consolidation and Post-transplant Maintenance in High-risk Patients With T-ALL (NCT05054465) | Israeli Medical Association | 2021-10-01 |
| Feasibility of Randomizing Danish Citizens Aged 65-79 Years to High-Dose Quadrivalent Influenza Vaccine vs. Standard-Dose Quadrivalent Influenza Vaccine in a Pragmatic Registry-Based Setting (NCT05048589) | Tor Biering-Sørensen | 2021-10-01 |
| Study of the Effect of Fostamatinib Upon Cutaneous Inflammation in the Setting of Hidradenitis Suppurativa (NCT05040698) | Holdsworth House Medical Practice | 2021-10-01 |
| Anlotinib Combined With Platinum/Gemcitabine for First Line Treatment of Advanced Urothelial Carcinoma (NCT05030077) | Tianjin Medical University Second Hospital | 2021-10-01 |
| A Study of ACI-24 in Adults With Down Syndrome (NCT04373616) | AC Immune SA | 2021-10-01 |
| Phase I/II Study of AloCelyvir in Patients With Metastatic Uveal Melanoma (NCT05047276) | José María Piulats Rodríguez | 2021-10-01 |
| Effects of Electrical Stimulation and Vitamin D Supplementation on Bone Health Following Spinal Cord Injury. (NCT05008484) | VA Office of Research and Development | 2021-10-01 |
| AT1001 for the Treatment of COVID-19 Related MIS-C (NCT05022303) | Massachusetts General Hospital | 2021-10-01 |
| A Study to Evaluate the Efficacy and Safety of SG001 in Combination With Nab-Paclitaxel in Patients With Advanced Triple-Negative Breast Cancer (TNBC) (NCT05068141) | CSPC ZhongQi Pharmaceutical Technology Co., Ltd. | 2021-10-01 |
| Hydroxychloroquine in Isolated Cutaneous Mastocytosis Patients or Indolent Systemic Mastocytosis With Associated Skin Involvement Patients (NCT05084872) | University Hospital, Toulouse | 2021-10-01 |
| Nab-paclitaxel Combined With Oxaliplatin and S-1 for Perioperative Treatment of Advanced Gastric Cancer (NCT05052931) | Jianjun Yang | 2021-10-01 |
| A Study of Pevonedistat Combined With Decitabine and Cedazuridine in Adults With Higher-risk Myelodysplastic Syndromes (NCT04985656) | Takeda | 2021-10-01 |